Marcy Darnovsky

Marcy Darnovsky, PhD, speaks and writes widely on the politics of human biotechnology, focusing on their social justice and public interest implications. Her articles have appeared in The New York Times, Nature, The Guardian, Los Angeles Times, Wall Street Journal, Harvard Law and Policy Review, Democracy, New Scientist and many others. She has appeared on dozens of television, radio, and online news shows and has been interviewed and cited in hundreds of news and magazine articles. She has worked as an organizer and advocate in a range of environmental and progressive political movements, and taught courses at Sonoma State University and at California State University East Bay. Her Ph.D. is from the History of Consciousness program at the University of California, Santa Cruz.

Profile picture for user Marcy Darnovsky

Publications

By Susan Berke Fogel, Francine Coeytaux, Marcy Darnovsky, Lisa Ikemoto, and Judy Norsigian, RH Reality Check | 04.23.2014
It is troubling to see the vexing question of commercial surrogacy treated as a litmus test for feminists at RH...
By Marcy Darnovsky; Jessica Cussins, Medical Laboratory Observer | 03.10.2014

Direct-to-consumer (DTC) genetic testing gained notoriety in the autumn of 2008. That was when two prestigious publications, The New Yorker...

By Marcy Darnovsky, The New York Times | 02.23.2014

An advisory committee of the Food and Drug Administration is set to begin two days of meetings tomorrow to consider...

In the News

a doctor with white hair explains a medical procedure to a young white couple with brown hair
By Kelly Glass, Medium Elemental [cites CGS' Marcy Darnovsky] | 11.06.2019

When Pamela Mahoney Tsigdinos and her husband were trying to conceive with in vitro fertilization (IVF), they were presented with...

abstract image of circles in blue, pink, and green
By Emily Mullin, Medium One Zero [cites CGS' Marcy Darnovsky] | 10.15.2019

An experimental and much-hyped reproductive procedure that mixes DNA from three people is not effective at boosting the chances of...

By Ana B. Ibarra, California Healthline [cites CGS' Marcy Darnovsky] | 08.15.2019

Californians voted in 2004 to shell out billions of dollars in taxpayer money to fund cutting-edge stem cell treatments.

Proposition...

Biopolitical Times